Bloomberg News

D.N.A Biomedical Jumps Most in a Year on FDA Device Approval

October 16, 2011

(Updates with closing share price in second paragraph.)

Oct. 16 (Bloomberg) -- D.N.A. Biomedical Solutions Ltd. gained the most in a year after the U.S. Food and Drug Administration approved the marketing of its MiniOmni device.

The shares surged 16 percent, the biggest jump since October 2010, to 0.193 shekel at the 2:45 p.m. close in Tel Aviv, giving the company based in that city a market value of 29.1 million shekels ($8 million).

--Editors: Susan Lerner, Claudia Maedler

To contact the reporter on this story: Gwen Ackerman in Jerusalem at gackerman@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


Burger King's Young Buns
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus